Search
for
Sort by
Research 961–990 of 1000+
- Autologous Platelet-Rich Plasma (PRP) for Treating Androgenetic Alopecia: A Novel Treatment Protocol Standardized on 2 Cases
- Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic review and meta-analysis
- Evaluation of hair regrowth in men with androgenetic alopecia treated with autologous platelet-rich plasma
- Clinical, Trichoscopic And Immunohistochemical Evaluation of Autologous Adipose Derived Adult Stem Cell Injection in the Treatment of Female Pattern Hair Loss
- Autologous stromal vascular fraction cells combined with platelet-rich plasma for androgenic alopecia treatment: a case series
- Comparison of efficacy of topical 5% minoxidil alone versus topical 5% minoxidil with autologous Platelet Rich Plasma (PRP) therapy in treatment of androgenetic alopecia: A randomised open label study
- Efficacy of Autologous Platelet Rich Plasma in the Treatment of Male Androgenetic Alopecia
- Autologous Platelet-Rich Plasma in the treatment of androgenetic alopecia: results of a 54-patient prospective study
- Evaluation of the effect of autologous platelet-rich plasma on androgenic alopecia
- My Experiences in Using Autologous Human Hair Follicular Stem Cells (AMT) With Regenera Technology Combination With Platelet Rich Plasma (PRP) for Androgenetic Alopecia Treatments – in Both Male Pattern Hair Loss (MPHL)&Female Pattern Hair Loss (FPHL) in Asian Populations.
- Combination of a non-ablative 1,927 nm thulium fiber fractional laser and autologous platelet-rich plasma in treatment of male androgenetic alopecia: A pilot study
- Efficacy of Autologous Platelet-Rich Plasma alone or in Combination with a Lotion Containing Growth-Factor like Polypeptides and Taurine in the Treatment of Androgenic Alopecia: A Randomized, Prospective, AssessorBlinded Trial
- Histological findings of follicular units in patients with androgenetic alopecia before and after application of autologous platelet-rich plasma.
- Autonomous, Moisture‐Driven Flexible Electrogenerative Dressing for Enhanced Wound Healing
- AI03 Steps towards safely deploying the world’s first autonomous artificial intelligence as a medical device for skin cancer into a National Health Service teledermatology pathway
- Do autologous platelet concentrates (APCs) have a role in intra‐oral bone regeneration? A critical review of clinical guidelines on decision‐making process
- Comparison of the Efficacy of Homologous and Autologous Platelet-Rich Plasma (PRP) for Treating Androgenic Alopecia
- Micro-autologous Fat Transplantation (MAFT) for Forehead Volumizing and Contouring
- Comparative Efficacy of Topical Calcipotriol, Intralesional Autologous Platelet-Rich Plasma Injection, and Combined Topical Calcipotriol with Intralesional Autologous Platelet-Rich Plasma Injection on Patients with Alopecia Areata
- 281 Phase I/IIa clinical trial for the treatment of androgenetic alopecia using intradermal injections of cultured autologous dermal sheath cup cells
- Receptor tyrosine kinase Kit action in skin melanocytes: is it exclusively cell autonomous?
- Therapeutic efficacy of autologous platelet-rich plasma and polydeoxyribonucleotide on female pattern hair loss
- Effects of autologous platelet‑rich plasma injections on facial skin rejuvenation
- Pilot study: Autologous platelet‐rich plasma used in a topical cream for facial rejuvenation
- Cell Enriched Autologous Fat Grafts to Follicular Niche Improves Hair Regrowth in Early Androgenetic Alopecia
- Combination of autologous FCS and MPG versus each technique alone in the treatment of stable vitiligo
- Using platelet-enriched autologous plasma for treatment of non-scarring alopecias (androgenetic and circumscribed alopecia)
- Efficacy and safety of autologous hematopoietic stem cell transplantation in treating type 1 diabetes mellitus
- Efficacy of Prophylactic Autologous Platelet-rich Plasma in Cesarean Wound Healing
- Correction to “Efficacy of Autologous Dermal Sheath Cup Cell Transplantation in Male and Female Pattern Hair Loss: A Single‐Arm, Multi‐Center, Phase III Equivalent Clinical Study”